Company intelligence / Profile preview

IntroMedic

Seoul, Seoul, South Korea

Ownership: Private
Employees: ~50
Development stage: Other

Overview

IntroMedic is a commercial-stage South Korean medtech company specializing in minimally invasive capsule endoscopy systems. Its flagship product, MiroCam®, is used for visualization of the small bowel and is available in over 80 countries. The company has also developed E.G. Scan™ for esophagus and stomach imaging and EndoClot for hemostasis. Clinical data supports the utility of MiroCam® in detecting small bowel lesions, and the company has participated in clinical trials comparing magnetically assisted capsule endoscopy to conventional methods.

Therapeutic areas: Gastroenterology
Modalities: Device
Industry: Medical Imaging

Partnerships

Korea Science and Technology CorporationGachen Medical Device Convergence Centerglobal distribution partners in over 80 countries

Beyond the preview

Go deeper on IntroMedic.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IntroMedic.

Explore the full profile